Stockreport

Starpharma Signs Second Oncology Agreement With AstraZeneca

STARPHARMA HLDGS S/ADR  (SPHRY) 
NASDAQ:AMEX Investor Relations: starpharma.com/investor_centre
PDF Starpharma has signed a Development and Option Agreement with AstraZeneca to progress the development of a Dendrimer Enhanced Product (DEP®) [Read more]